Zimmer Biomet (NYSE:ZBH) & Generation Alpha (OTCMKTS:GNAL) Head to Head Comparison

Zimmer Biomet (NYSE:ZBH) and Generation Alpha (OTCMKTS:GNAL) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, risk, earnings, dividends, analyst recommendations, institutional ownership and profitability.

Valuation & Earnings

This table compares Zimmer Biomet and Generation Alpha”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zimmer Biomet	$8.23 billion	2.24	$705.20 million	$3.54	26.97
Generation Alpha	N/A	N/A	N/A	N/A	N/A

Zimmer Biomet has higher revenue and earnings than Generation Alpha.

Analyst Ratings

This is a summary of recent ratings and price targets for Zimmer Biomet and Generation Alpha, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zimmer Biomet	3	12	7	1	2.26
Generation Alpha	0	0	0	0	0.00

Zimmer Biomet presently has a consensus price target of $105.95, suggesting a potential upside of 10.99%. Given Zimmer Biomet’s stronger consensus rating and higher probable upside, research analysts plainly believe Zimmer Biomet is more favorable than Generation Alpha.

Profitability

This table compares Zimmer Biomet and Generation Alpha’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Zimmer Biomet	8.56%	12.93%	7.11%
Generation Alpha	N/A	N/A	N/A

Risk & Volatility

Zimmer Biomet has a beta of 0.61, meaning that its share price is 39% less volatile than the S&P 500. Comparatively, Generation Alpha has a beta of 2.02, meaning that its share price is 102% more volatile than the S&P 500.

Insider & Institutional Ownership

88.9% of Zimmer Biomet shares are held by institutional investors. 1.3% of Zimmer Biomet shares are held by company insiders. Comparatively, 60.8% of Generation Alpha shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Zimmer Biomet beats Generation Alpha on 9 of the 11 factors compared between the two stocks.

About Zimmer Biomet

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

About Generation Alpha

Generation Alpha, Inc. focuses on the research, design, development, and manufacturing of indoor horticulture lighting, plant nutrient products, and ancillary equipment in the United States and internationally. The company offers digital ballasts; metal halide, and mercury vapor and high-pressure sodium lamps; light emitting diode lighting products that produce less heat; digital lighting controller, a temperature monitoring control system; reflectors; and high intensity lighting accessories, as well as plant nutrients and fertilizers. It primarily serves commercial and retail cannabis growers in the medical and adult use recreational markets; distributors; and retailers. Generation Alpha, Inc. markets its products directly; and through distributors to hydroponic retailers, as well as through direct contacts, online email advertising, social media, trade magazine advertising, trade show promotions, and cross-promotional offerings, as well as ecommerce websites. The company was formerly known as Solis Tek Inc. Generation Alpha, Inc. was incorporated in 2007 and is based in Upland, California.